VANGUARD GROUP INC 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-08-12 10:06 am Purchase | 2024-07-31 | 13G | Integra LifeSciences Holdings Corporation IART | VANGUARD GROUP INC | 7,802,615 10.060% | 789,822![]() (+11.26%) | Filing |
2024-02-13 5:06 pm Sale | 2023-12-29 | 13G | Integra LifeSciences Holdings Corporation IART | VANGUARD GROUP INC | 7,012,793 8.970% | -134,966![]() (-1.89%) | Filing |
2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Integra LifeSciences Holdings Corporation IART | VANGUARD GROUP INC | 7,147,759 8.560% | 488,637![]() (+7.34%) | Filing |
2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | VANGUARD GROUP INC | 6,659,122 7.860% | 184,581![]() (+2.85%) | Filing |
2021-02-10 11:03 am Sale | 2020-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | VANGUARD GROUP INC | 6,474,541 7.680% | -176,158![]() (-2.65%) | Filing |